Research Articles
Arresting Autoimmunity: How Blocking β-Arrestin 1 Could Revolutionize Autoimmune Disease Treatment
Discover how β-arrestin 1 blockade offers promising new approaches for treating autoimmune diseases like multiple sclerosis and rheumatoid arthritis.
KIAA1199: The "Jekyll and Hyde" Molecule in Our Cells
Discover the dual role of KIAA1199 protein - from hearing function to cancer progression and immunotherapy resistance.
MLAA-22: The 'Smart Bomb' Antigen Revolutionizing Leukemia Treatment
Discover how MLAA-22, a novel antigen identified through computational biology, is transforming leukemia treatment with its precision targeting capabilities.
The Cellular "Homeless" Signal: A New Clue to Stopping Digestive Cancers
Discover how cellular 'homelessness' (anoikis) predicts survival and immunotherapy response in gastrointestinal cancers through groundbreaking research.
Breaking the Toxic Chain: How Blocking Hyaluronan Could Revolutionize Cancer Immunotherapy
Discover how blocking hyaluronan could prevent dangerous side effects of IL-2 cancer immunotherapy while maintaining its effectiveness against melanoma.
The Secret Power-Up Inside Our Cancer-Fighting Cells
How mitochondrial metabolic flexibility gives CD8 T cells the ability to fight cancer more effectively
Training the Body's Assassins: A New Front in the Fight Against Mesothelioma
How scientists are using a clever cellular trick to turn cancer against itself through apoptotic cell-pulsed dendritic cell vaccination.
A Double Whammy for Prostate Cancer: Unleashing the Immune System with a One-Two Punch
Discover how combining Ibrutinib with PD-1 checkpoint blockade creates a powerful immunotherapy approach for metastatic prostate cancer.
Rewiring Immunity: How Engineering T-Cell Receptors Could Revolutionize Liver Cancer Treatment
Exploring TCR Vβ7 transfection into PBLs and its potential anti-hepatoma effects in liver cancer immunotherapy.
Radiation Therapy Revolution: New Approaches in Head and Neck Cancer Treatment
Breakthrough advances in radiation therapy for head and neck cancers from ASCO and ESMO 2022, focusing on precision, immunotherapy, and molecular targets.